Get started
Author

Shohei Anno

Observed names: S Anno, S. Anno
ORCID: 0000-0002-7439-0721
Observed ORCID: 0000-0002-7439-0721
OpenAlex ID: A5089728559
Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study
2017 · Masahiro Tada, Kentaro Inui, et al. · Rheumatology International · 21
Comparison of median nerve stiffness with and without rheumatoid arthritis by ultrasound real-time tissue elastography: A propensity score matching study
2019 · Shohei Anno, Tadashi Okano, et al. · Modern Rheumatology · 11
Evaluation of work disability in Japanese patients with rheumatoid arthritis: from the TOMORROW study
2018 · Shohei Anno, Yuko Sugioka, et al. · Clinical Rheumatology · 9
Comparison of creatine kinase elevation caused by Janus kinase inhibitors and interleukin-6 inhibitors in patients with rheumatoid arthritis: A propensity score-matched study
2024 · Masahiro Tada, Tadashi Okano, et al. · Archives of Rheumatology · 7
PDF
Biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease‐modifying anti‐rheumatic drugs: Results from the PRESENT study
2024 · Masahiro Tada, Yoshinari Matsumoto, et al. · International Journal of Rheumatic Diseases · 6
Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis
2024 · Shohei Anno, Tadashi Okano, et al. · Modern Rheumatology · 6
Glucocorticoid usage is involved in the improvement and development of frailty in patients with rheumatoid arthritis: Results from the PRESENT study
2025 · Masahiro Tada, Yoshinari Matsumoto, et al. · Geriatrics and gerontology international/Geriatrics & gerontology international · 3
Change of autoantibody levels in established rheumatoid arthritis patients treated by biological disease-modifying anti-rheumatic drugs -the AIRTIGHT study-
2025 · Shohei Anno, Kentaro Inui, et al. · Journal of Rheumatic Diseases · 2
PDF
AB0481 Abatacept Might not Alter Anti-Cyclic Citrullinated Peptide Levels in Established Rheumatoid Arthritis Patients -Airtight Study-
2015 · S. Anno, K. Inui, et al. · Annals of the Rheumatic Diseases · 2
Biological/targeted synthetic disease–modifying antirheumatic drugs improve not only muscle mass but also phase angle in patients with rheumatoid arthritis
2025 · Masahiro Tada, Yoshinari Matsumoto, et al. · Clinical Rheumatology · 1
Romosozumab increases bone mineral density in Japanese older adults with osteoporosis
2025 · Shohei Anno, Tadashi Okano, et al. · Modern Rheumatology · 1
Ab0192 Analysis of Ultrasound Findings in Patients With Difficult to Treat Rheumatoid Arthritis
2023 · T. Okano, K. Mamoto, et al. · Annals of the Rheumatic Diseases · 1
PDF
Incidence of new carotid plaques in rheumatoid arthritis patients: 6-Year prospective results of the TOMORROW study
2022 · Shohei Anno, Tadashi Okano, et al. · Modern Rheumatology · 1
Ab0115 Comparison of Ultrasound Findings Between Tnf Inhibitors and Non-tnf Inhibitors at First Biologics in Patients With Rheumatoid Arthritis
2021 · T. Okano, T. Koike, et al. · Annals of the Rheumatic Diseases · 1
Fri0051 Rheumatoid Arthritis Patients With High Disease Activity and Treated With High Dose Glucocorticoid Frequently Fall: Nine Years of the Tomorrow Study
2020 · S. Anno, Y. Sugioka, et al. · Annals of the Rheumatic Diseases · 1
Structural remission rate and factors associated with radiographic progression in patients with rheumatoid arthritis treated with sarilumab in clinical practice
2026 · Masahiro Tada, Katsuaki Onishi, et al. · Clinical Rheumatology
POS0032 Effectiveness of Switching from IL-6 Inhibitors to Other Targeted Molecular Therapies
2025 · T. Okano, K. Mamoto, et al. · Annals of the Rheumatic Diseases
Abs0812 Comparison of the Clinical Effects of Jak Inhibitors and Il-6 Inhibitors in the Patients With Rheumatoid Arthritis
2025 · K. Mamoto, T. Okano, et al. · Annals of the Rheumatic Diseases
Op0181 Which Mode of Action Is Best for Difficult-to-treat Rheumatoid Arthritis When Switching Biologics or Jak Inhibitors?
2024 · T. Tachibana, Y. Yamada, et al. · Annals of the Rheumatic Diseases
Ab0528 Therapeutic Effecacy of Jak Inhibitors With or Without Methotrexate in Patients With Rheumatoid Arthritis
2024 · T. Okano, C. Yoshimura, et al. · Annals of the Rheumatic Diseases
Pos0822 Does Concomitant/non-concomitant Use of Mtx With Biologics and Jak Inhibitors Affect Ultrasound Finding of Intra-articular Synovitis?
2023 · T. Okano, K. Mamoto, et al. · Annals of the Rheumatic Diseases
PDF
Ab1405 Postoperative Results of Joint-preserving Surgery With Mitchell's Osteotomy for Hallux Valgus Deformity in Patients With Rheumatoid Arthritis
2023 · C. Yoshimura, T. Okano, et al. · Annals of the Rheumatic Diseases
PDF
Ab0422 the Effects of Concomitant Use of Methotrexate in Patients With Rheumatoid Arthritis Treated With Sarilumab
2023 · S. Anno, T. Okano, et al. · Annals of the Rheumatic Diseases
PDF
Ab0326 Impact of Anti-citrullinated Protein Antibodies and Rheumatoid Factor on Bone Mineral Density Change in Rheumatoid Arthritis Patients Treated With Denosumab
2023 · S. Anno, T. Okano, et al. · Annals of the Rheumatic Diseases
PDF
Pos0840 the Difference in Creatine Kinase Elevation Caused by Jak Inhibitors and Il-6 Inhibitors in Rheumatoid Arthritis
2023 · M. Tada, T. Okano, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 37
Citation count: 73
H-index: 6
I10-index: 2
Year
Topic
Type